双鹭药业(002038.SZ)：目前奥司他韦订单数量有所增加

Group 1 - The core viewpoint of the article is that Shuanglu Pharmaceutical (002038.SZ) has seen an increase in orders for Oseltamivir and is closely monitoring the sales performance of this drug alongside other antiviral medications [1] Group 2 - The company is actively engaging with investors through an interactive platform to provide updates on its product sales [1] - There is a specific focus on the sales situation of Oseltamivir in relation to other anti-influenza drugs [1]